Keele Research Repository

Article

Guimond, SE ORCID: https://orcid.org/0000-0002-5903-418X, Mycroft-West, CJ, Gandhi, NS, Tree, JA, Le, TT, Spalluto, CM, Humbert, MV, Buttigieg, KR, Coombes, N, Elmore, MJ, Wand, M, Nyström, K, Said, J, Setoh, YX, Amarilla, AA, Modhiran, N, Sng, JDJ, Chhabra, M, Young, PR, Rawle, DJ, Lima, MA, Yates, EA, Karlsson, R, Miller, RL, Chen, Y-H, Bagdonaite, I, Yang, Z, Stewart, J, Nguyen, D, Laidlaw, S, Hammond, E, Dredge, K, Wilkinson, TMA, Watterson, D, Khromykh, AA, Suhrbier, A, Carroll, MW, Trybala, E, Bergström, T, Ferro, V, Skidmore, MA ORCID: https://orcid.org/0000-0002-0287-5594 and Turnbull, JE ORCID: https://orcid.org/0000-0002-1791-754X (2022) Synthetic Heparan Sulfate Mimetic Pixatimod (PG545) Potently Inhibits SARS-CoV-2 by Disrupting the Spike-ACE2 Interaction. ACS Central Science, 8 (5). 527 - 545.

Corrie, PG, Marshall, A, Nathan, PD, Lorigan, P, Gore, M, Tahir, S, Faust, G, Kelly, CG, Marples, M, Danson, SJ, Marshall, E, Houston, SJ, Board, RE, Waterston, AM, Nobes, JP, Harries, M, Kumar, S, Goodman, A, Dalgleish, A, Martin-Clavijo, A, Westwell, S, Casasola, R, Chao, D, Maraveyas, A, Patel, PM, Ottensmeier, CH, Farrugia, D, Humphreys, A, Eccles, B, Young, G, Barker, EO, Harman, C, Weiss, M, Myers, KA, Chhabra, A, Rodwell, SH, Dunn, JA, Middleton, MR, AVAST-M Investigators, Nathan, P, Lorigan, P, Dziewulski, P, Holikova, S, Panwar, U, Tahir, S, Faust, G, Thomas, A, Corrie, P, Sirohi, B, Kelly, C, Middleton, M, Marples, M, Danson, S, Lester, J, Marshall, E, Ajaz, M, Houston, S, Board, R, Eaton, D, Waterston, A, Nobes, J, Loo, S, Gray, G, Stubbings, H, Gore, M, Harries, M, Kumar, S, Goodman, A, Dalgleish, A, Martin-Clavijo, A, Marsden, J, Westwell, S, Casasola, R, Chao, D, Maraveyas, A, Marshall, E, Patel, P, Ottensmeier, C, Farrugia, D, Humphreys, A, Eccles, B, Dega, R, Herbert, C, Price, C, Brunt, M, Scott-Brown, M, Hamilton, J, Hayward, RL, Smyth, J, Woodings, P, Nayak, N, Burrows, L, Wolstenholme, V, Wagstaff, J, Nicolson, M, Wilson, A, Barlow, C, Scrase, C, Podd, T, Gonzalez, M, Stewart, J, Highley, M, Wolstenholme, V, Grumett, S, Goodman, A, Talbot, T, Nathan, K, Coltart, R, Gee, B, Gore, M, Farrugia, D, Martin-Clavijo, A, Marsden, J, Price, C, Farrugia, D, Nathan, K, Coltart, R, Nathan, K and Coltart, R (2018) Adjuvant bevacizumab for melanoma patients at high risk of recurrence: survival analysis of the AVAST-M trial. Annals of Oncology, 29 (8). 1843 -1852.